| 000 | 01740 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513091815.0 | ||
| 264 | 0 | _c19960826 | |
| 008 | 199608s 0 0 eng d | ||
| 022 | _a0021-9258 | ||
| 024 | 7 |
_a10.1074/jbc.271.23.13621 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHarnish, D C | |
| 245 | 0 | 0 |
_aControl of apolipoprotein AI gene expression through synergistic interactions between hepatocyte nuclear factors 3 and 4. _h[electronic resource] |
| 260 |
_bThe Journal of biological chemistry _cJun 1996 |
||
| 300 |
_a13621-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApolipoprotein A-I _xgenetics |
| 650 | 0 | 4 | _aBasic Helix-Loop-Helix Leucine Zipper Transcription Factors |
| 650 | 0 | 4 |
_aBinding Sites _xgenetics |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aDNA-Binding Proteins _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aEnhancer Elements, Genetic |
| 650 | 0 | 4 |
_aEstradiol _xpharmacology |
| 650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
| 650 | 0 | 4 | _aHeLa Cells |
| 650 | 0 | 4 | _aHepatocyte Nuclear Factor 3-beta |
| 650 | 0 | 4 | _aHepatocyte Nuclear Factor 4 |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aL Cells |
| 650 | 0 | 4 |
_aLiver _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNuclear Proteins _xadministration & dosage |
| 650 | 0 | 4 |
_aPhosphoproteins _xadministration & dosage |
| 650 | 0 | 4 |
_aTranscription Factors _xadministration & dosage |
| 700 | 1 | _aMalik, S | |
| 700 | 1 | _aKilbourne, E | |
| 700 | 1 | _aCosta, R | |
| 700 | 1 | _aKarathanasis, S K | |
| 773 | 0 |
_tThe Journal of biological chemistry _gvol. 271 _gno. 23 _gp. 13621-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1074/jbc.271.23.13621 _zAvailable from publisher's website |
| 999 |
_c8661589 _d8661589 |
||